SCHEMBL4777211

SCHEMBL4777211

CCCCCCCCCCCCCCCC1(O)CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1070145 1.00
SCHEMBL9637160 1.00
SCHEMBL1903763 1.00
SCHEMBL7673861 1.00
SCHEMBL386177 1.00
SCHEMBL3804023 0.89 LMNA (0.42)
SCHEMBL18423851 0.86 SIRT2 (0.37)
SCHEMBL5698597 0.84 SIRT2 (0.36)
SCHEMBL21353932 0.83 SIRT2 (0.35)
SCHEMBL9701164 0.82 CPT2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1516014-B1 POROUS GELATIN MATERIAL, GELATIN STRUCTURES, METHODS FOR PREPARATION OF THE SAME AND USES THEREOF CELLTRIX AB (SE) 2016-11-02 EP claimed
US-20240207411-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS SEAPORT THERAPEUTICS, INC. 2024-06-27 US disclosed
US-11975073-B2 Lipid prodrugs of neurosteroids PURETECH LYT, INC. (US) 2024-05-07 US disclosed
CN-117865872-A Tetrahydro-pyrido [3,4-b ] indole estrogen receptor modulators and uses thereof 豪夫迈·罗氏有限公司 2024-04-12 CN disclosed
US-11938137-B2 Lipid prodrugs of mycophenolic acid and uses thereof PURETECH LYT, INC. (US) 2024-03-26 US disclosed
US-20240050573-A1 LYMPH DIRECTING PRODRUGS MONASH UNIVERSITY (AU) 2024-02-15 US disclosed
WO-2024028316-A1 1H-PYRROLO[3,2-B]PYRIDINE DERIVATIVES AS IRREVERSIBLE INHIBITORS OF MUTANT EGFR FOR THE TREATMENT OF CANCER BAYER AKTIENGESELLSCHAFT (DE) 2024-02-08 WO disclosed
US-11883497-B2 Lymphatic system-directing lipid prodrugs PURETECH LYT, INC. (US) 2024-01-30 US disclosed
EP-4306524-A2 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS PureTech LYT, Inc. (US) 2024-01-17 EP disclosed
CN-112375078-B Tetrahydro-pyrido [3,4-b ] indole estrogen receptor modulators and uses thereof 豪夫迈·罗氏有限公司 2023-12-19 CN disclosed
EP-0159565-A1 Substituted 2,3,3alpha,6-tetrahydro-6-oxabenzofuran derivatives useful as paf antagonists MERCK & CO. INC. (US) 1985-10-30 EP disclosed
EP-0154887-A1 New 2,5-diaryl tetrahydrothiophenes and analogs thereof as paf-antagonists MERCK & CO. INC. (US) 1985-09-18 EP disclosed
EP-0151687-A1 Process for the isolation of 5-Allyl-2-(3,4-dimethoxyphenyl)-3a-methoxy-3-methyl-2,3,3a,6-tetrahydro-6-oxobenzofuran and pharmaceutical composition for treating inflammatory conditions MERCK & CO. INC. (US) 1985-08-21 EP disclosed
EP-0144804-A2 New 2,5-diaryl tetrahydrofurans and analogs thereof as paf-antagonists MERCK & CO. INC. (US) 1985-06-19 EP disclosed
EP-0142801-A2 Indene derivatives useful as paf-antagonists MERCK & CO. INC. (US) 1985-05-29 EP disclosed
EP-0124081-A2 New substituted cephalosporin sulfones as antiinflammatory and antidegenerative agents, pharmaceutical compositions containing the same and processes for making them MERCK & CO. INC. (US) 1984-11-07 EP disclosed
EP-0109036-A1 Anti-inflammatory/analgesic combination of alpha-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID) MERCK & CO. INC. (US) 1984-05-23 EP disclosed
EP-0083779-A1 Hyperuretic agents Beyer, Karl H., Jr. (US) 1983-07-20 EP disclosed
EP-0081823-A1 Composition for reducing menstrual pain WHITBY RESEARCH, Inc. (US) 1983-06-22 EP disclosed
US-4135879-A PHOSPHORIC ACID ESTERS OF POLYOXYETHYLATED ALKANOLS AND/OR SALTS THEREOF CHEMISCHE FABRIK KREUSSLER & CO., GMBH (DE) 1979-01-23 US disclosed